2024
Prophylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
Nellis M, Moynihan K, Sloan S, Delaney M, Kneyber M, DiGeronimo R, Alexander P, Muszynski J, Gehred A, Lyman E, Karam O, in collaboration with the Pediatric Critical Care Blood Research Network A. Prophylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference. Pediatric Critical Care Medicine 2024, 25: e25-e34. PMID: 38959357, PMCID: PMC11216389, DOI: 10.1097/pcc.0000000000003493.Peer-Reviewed Original ResearchConceptsExtracorporeal membrane oxygenationProphylactic transfusion strategyTransfusion strategyMembrane oxygenationProphylactic blood product transfusionsPediatric extracorporeal membrane oxygenationConsensus statementPediatric ECMO patientsBlood product transfusionExpert consensus statementPractice statementsStandardized data extraction formProphylactic transfusionECMO patientsProduct transfusionModified Delphi consensusWeak recommendationConsensus conferenceRecommendations AssessmentData extraction formDelphi processStudy assessed useModified Delphi processLiterature searchDelphi consensus
2023
Impact of intraoperative blood products, fluid administration, and persistent hypothermia on bleeding leading to reexploration after cardiac surgery
Shou B, Zhou A, Ong C, Alejo D, DiNatale J, Larson E, Lawton J, Schena S. Impact of intraoperative blood products, fluid administration, and persistent hypothermia on bleeding leading to reexploration after cardiac surgery. Journal Of Thoracic And Cardiovascular Surgery 2023, 168: 873-884.e4. PMID: 37839660, DOI: 10.1016/j.jtcvs.2023.10.011.Peer-Reviewed Original ResearchIntraoperative blood product transfusionIntensive care unit arrivalCore body temperatureBlood product transfusionCardiac surgeryPerioperative bleedingProduct transfusionCrystalloid administrationFluid administrationUnit arrivalRisk factorsAdult cardiac surgery patientsGreater postoperative morbidityIntraoperative blood productsSevere postoperative bleedingCardiac surgery patientsBlood product administrationIntravenous fluid administrationLower core body temperatureSuch risk factorsElectronic medical recordsPersistent hypothermiaPostoperative bleedingPostoperative morbidityIntraoperative fluid
2022
Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized Controlled Trials
Hartmann J, Dias J, Pivalizza E, Garcia-Tsao G. Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized Controlled Trials. Seminars In Thrombosis And Hemostasis 2022 DOI: 10.1055/s-0042-1757135.Peer-Reviewed Original ResearchPatient blood managementBlood productsAdult patientsAdverse eventsBlood managementIntensive care unit stayIndividual blood productsLess blood productsBlood product useCo-primary outcomesLong-term mortalityFresh frozen plasma unitsRisk of hemorrhageRandomized Controlled TrialsRegistered Systematic ReviewUse of thromboelastographyFrozen plasma unitsBleeding eventsFFP useUnit stayProduct transfusionTerm mortalityCirrhotic patientsCoagulation statusPlatelet useEndoscopic vs Open Vein Harvest in Drug-Eluting Stents or Bypass Surgery for Left Main Disease Trial
Jarrett C, Pelletier M, Abu-Omar Y, Baeza C, Elgudin Y, Markowitz A, Vega P, Dressler O, Kappetein A, Serruys P, Stone G, Sabik J. Endoscopic vs Open Vein Harvest in Drug-Eluting Stents or Bypass Surgery for Left Main Disease Trial. The Annals Of Thoracic Surgery 2022, 115: 72-78. PMID: 35283098, DOI: 10.1016/j.athoracsur.2021.12.079.Peer-Reviewed Original ResearchConceptsEndoscopic vein harvesting groupCoronary Artery Bypass GraftingOpen vein harvestingEndoscopic vein harvestingIschemia-driven revascularizationOpen vein harvested patientsBlood product transfusionComposite of deathGraft stenosisProduct transfusionVein harvestingEndoscopic vein harvest patientsOpen vein harvesting groupMyocardial infarctionOutcomes of coronary artery bypass graftingPrimary end pointArtery Bypass GraftingIn-Hospital BleedingKaplan-Meier estimatesTime-to-first-event analysisDrug-eluting stentsBypass surgeryBypass GraftingVenous graftsEnd points
2021
Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial
Sera VA, Stevens AE, Song HK, Rodriguez VM, Tibayan FA, Treggiari MM. Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial. Pilot And Feasibility Studies 2021, 7: 137. PMID: 34215339, PMCID: PMC8252226, DOI: 10.1186/s40814-021-00873-5.Peer-Reviewed Original ResearchFactor Eight Inhibitor Bypassing ActivityCardiac surgeryPilot trialTransfusion requirementsRescue therapyLarge trialsProtocol adherenceBlood productsHigh-risk cardiac surgeryProthrombin complex concentrate administrationPlacebo-controlled pilot trialFactor VIII inhibitor bypass activityLarge pivotal trialsReduction of transfusionBlood product transfusionEnd of CPBTertiary referral hospitalHypothermic circulatory arrestTermination of CPBPost-cardiopulmonary bypassProthrombin complex concentrateBlinded administrationProduct transfusionResultsTwenty patientsStudy drugVariation in Neonatal Transfusion Practice
Patel RM, Hendrickson JE, Nellis ME, Birch R, Goel R, Karam O, Karafin MS, Hanson SJ, Sachais BS, Hauser RG, Luban NLC, Gottschall J, Josephson CD, Sola-Visner M, National Heart L, Mast A, Hod E, Custer B, Vichinsky E, Spencer B, Mathew S, Harris D, Busch M, Norris P, Ness P, Kleinman S, Tamburro R, Glynn S, Malkin K. Variation in Neonatal Transfusion Practice. The Journal Of Pediatrics 2021, 235: 92-99.e4. PMID: 33836184, PMCID: PMC8316298, DOI: 10.1016/j.jpeds.2021.04.002.Peer-Reviewed Original ResearchConceptsWeeks of gestationEntire cohortPretransfusion hemoglobinPlatelet countNeonatal transfusionBlood Institute Recipient EpidemiologyDonor Evaluation Study-IIIInternational normalized ratio (INR) valuesHematologic valuesNeonatal transfusion practicesPretransfusion platelet countRetrospective cohort studyBlood product transfusionGestational age groupsPatient blood managementNational Heart LungRecipient EpidemiologyInitial hospitalizationProduct transfusionCohort studyRed blood cellsGestational ageTransfusion practiceHeart LungBlood management
2020
The effect of anticoagulation on outcomes after liver and spleen injuries: A research consortium of New England centers for trauma (ReCONECT) study
Bhattacharya B, Askari R, Davis KA, Dorfman J, Eid AI, Elsharkawy AE, Kasotakis G, Mackey S, Odom S, Okafor BU, Rosenblatt M, Ruditsky A, Velmahos G, Maung AA. The effect of anticoagulation on outcomes after liver and spleen injuries: A research consortium of New England centers for trauma (ReCONECT) study. Injury 2020, 51: 1994-1998. PMID: 32482426, DOI: 10.1016/j.injury.2020.05.002.Peer-Reviewed Original ResearchConceptsNon-ACS patientsEffect of anticoagulationNon-operative managementSpleen injurySplenic injuryLiver injuryInitial non-operative managementSignificant differencesUse of anticoagulationBlood product transfusionMulticenter retrospective studyAC drugsMore PRBCsInjury gradeProduct transfusionCommon indicationAC patientsAtrial fibrillationRetrospective studyAnticoagulationSolid organsPatientsInjuryStudy periodLiver
2019
Perihematomal Edema After Intracerebral Hemorrhage in Patients With Active Malignancy
Gusdon AM, Nyquist PA, Torres-Lopez VM, Leasure AC, Falcone GJ, Sheth KN, Sansing LH, Hanley DF, Malani R. Perihematomal Edema After Intracerebral Hemorrhage in Patients With Active Malignancy. Stroke 2019, 51: 129-136. PMID: 31744426, PMCID: PMC7048624, DOI: 10.1161/strokeaha.119.027085.Peer-Reviewed Original ResearchConceptsBlood product transfusionThirty-day mortalityIntracerebral hemorrhagePerihematomal edemaActive malignancyProduct transfusionPHE volumeICH volumeActive cancerPHE growthPlatelet transfusionsCentral nervous system involvementRecurrence of malignancyNervous system involvementNontraumatic intracerebral hemorrhageCancer-specific dataPHE expansionRecent chemotherapyChart reviewConclusions PatientsControl patientsMost patientsHematoma volumeInstitutional databaseSystem involvementContemporary management of spontaneous retroperitoneal and rectus sheath hematomas
Warren MH, Bhattacharya B, Maung AA, Davis KA. Contemporary management of spontaneous retroperitoneal and rectus sheath hematomas. The American Journal Of Surgery 2019, 219: 707-710. PMID: 31109633, DOI: 10.1016/j.amjsurg.2019.05.002.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAngiographyAnticoagulantsBlood Component TransfusionEmbolization, TherapeuticFemaleHematomaHumansInternational Normalized RatioLength of StayMaleMiddle AgedPlatelet Aggregation InhibitorsProthrombin TimeRectal DiseasesRetroperitoneal SpaceRetrospective StudiesShock, HemorrhagicTomography, X-Ray ComputedConceptsSheath hematomaSurgical interventionBlood product transfusionOptimal treatment strategySpontaneous retroperitonealIntravenous heparinProduct transfusionAdult patientsMedian ageAntiplatelet agentsHemorrhagic shockDisease progressionBlood productsTreatment strategiesCT scanHematomaOutcome dataPatientsOne-year periodContemporary managementSpecific agentsAngioembolizationRetroperitonealInterventionAgentsAssociation Between Cannabis Use and Complications Related to Crohn’s Disease: A Retrospective Cohort Study
Mbachi C, Attar B, Wang Y, Paintsil I, Mba B, Fugar S, Agrawal R, Simons-Linares R, Jaiswal P, Trick W, Kotwal V. Association Between Cannabis Use and Complications Related to Crohn’s Disease: A Retrospective Cohort Study. Digestive Diseases And Sciences 2019, 64: 2939-2944. PMID: 30825109, DOI: 10.1007/s10620-019-05556-z.Peer-Reviewed Original ResearchConceptsDisease-related complicationsCrohn's diseaseRelated complicationsDisease patientsPrimary diagnosisCannabis usersCrohn's disease-related complicationsUtilization Project National Inpatient SampleIdiopathic inflammatory processParenteral nutrition requirementRetrospective cohort studyBlood product transfusionIntra-abdominal abscessPropensity score matchAnti-inflammatory effectsCrohn's disease patientsEffects of cannabisBackgroundCrohn’s diseaseProduct transfusionCohort studyIntestinal inflammationSignificant morbiditySecondary diagnosisHospital inpatientsInpatient Sample
2018
Acute kidney injury, but not sepsis, is associated with higher procedure‐related bleeding in patients with decompensated cirrhosis
Hung A, Garcia‐Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure‐related bleeding in patients with decompensated cirrhosis. Liver International 2018, 38: 1437-1441. PMID: 29393567, PMCID: PMC6072624, DOI: 10.1111/liv.13712.Peer-Reviewed Original ResearchConceptsAcute kidney injuryProcedure-related bleedingKidney injuryPost-procedure bleedingRisk factorsCT scanEnd-stage renal diseaseInfection/sepsisAbnormal coagulation parametersBlood product transfusionLarge-volume paracentesisNon-cirrhotic patientsRetrospective chart reviewOnly independent predictorUnstratified cohortsMELD scoreProduct transfusionAdverse eventsChart reviewPatient characteristicsCirrhosis patientsIndependent predictorsRenal diseaseHemoglobin levelsCoagulation parameters
2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Pine AB, Lee E, Sekeres M, Steensma DP, Zelterman D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba HP, Garcia‐Manero G, Lee AI, Podoltsev NA, Barbarotta L, Kasberg S, Hendrickson JE, Gore SD, Zeidan AM. Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. Transfusion 2016, 57: 289-295. PMID: 27878822, PMCID: PMC5309168, DOI: 10.1111/trf.13934.Peer-Reviewed Original ResearchConceptsAcute leukemiaTransfusion practiceBlood productsTransfusion patternsAL patientsHigh-quality trial evidenceBlood product transfusionBone marrow biopsyEvidence-based guidelinesClinical outcome dataRed blood cell productsBlood cell productsTransfusion goalsProduct transfusionTransfusion triggerUnnecessary transfusionsAmbulatory patientsCryoprecipitate transfusionMarrow biopsyTrial evidenceLumbar punctureSupportive managementCare settingsInvasive proceduresOutcome dataThe association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes
Einerson BD, Son M, Schneider P, Fields I, Miller ES. The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. American Journal Of Obstetrics And Gynecology 2016, 216: 300.e1-300.e5. PMID: 27823918, DOI: 10.1016/j.ajog.2016.10.040.Peer-Reviewed Original ResearchConceptsIntrauterine balloon tamponadeIntensive care unit admissionCare unit admissionBlood product transfusionBalloon tamponadePostpartum feverPostpartum hemorrhageTamponade durationUnit admissionHospital lengthProduct transfusionBlood lossClinical outcomesMaternal intensive care unit admissionPacked red blood cellsMultivariable logistic regression modelHemorrhage-related outcomesMean hospital lengthRetrospective cohort studyFirst-line treatmentUterine artery embolizationLength of stayLack of associationLogistic regression modelsArtery embolizationPrediction of Catheter-Associated Thrombosis in Critically Ill Children
Marquez A, Shabanova V, Faustino EV. Prediction of Catheter-Associated Thrombosis in Critically Ill Children. Pediatric Critical Care Medicine 2016, 17: e521-e528. PMID: 27662566, DOI: 10.1097/pcc.0000000000000958.Peer-Reviewed Original ResearchConceptsCatheter-associated thrombosisCentral venous cathetersVenous cathetersIll childrenRecent surgeryHigh riskCatheter-associated deep venous thrombosisMulticenter prospective cohort studyBlood product transfusionDeep venous thrombosisProspective cohort studyCritically Ill ChildrenSeverity of illnessRisk prediction modelProduct transfusionCohort studyVenous thrombosisGroup of childrenSubclavian veinActive surveillanceThrombosisCatheterSecondary analysisLogistic regressionCharacteristic curve
2015
North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia
Pine A, Lee E, Sekeres M, Steensma D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba H, Garcia-Manero G, Lee A, Podoltsev N, Barbarotta L, Hendrickson J, Gore S, Zeidan A. North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia. Blood 2015, 126: 1138. DOI: 10.1182/blood.v126.23.1138.1138.Peer-Reviewed Original ResearchRed blood cell transfusionNon-bleeding patientsBlood cell transfusionBone marrow biopsyBlood product transfusionSouthwest Oncology GroupPlatelet transfusionsOutpatient settingAcute leukemiaPlatelet levelsCell transfusionHemoglobin levelsTransfusion practiceLumbar punctureFibrinogen levelsProduct transfusionHospitalized patientsOncology GroupClinical trialsPlatelet thresholdMost respondersConsensus evidence-based guidelinesMost providersEastern Cooperative Oncology GroupStable hospitalized patientsSubgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty
Anazonwu W, Tuttle J, Rubin L. Subgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty. Reconstructive Review 2015, 5: 80-80. DOI: 10.15438/rr.5.1.80.Peer-Reviewed Original ResearchTotal hip arthroplastyPrimary total hip arthroplastyTopical tranexamic acidTranexamic acidTXA administrationBlood lossHip arthroplastyBlood product transfusionSpecific patient groupsTotal joint arthroplastyPreoperative hemoglobinTransfusion reductionProduct transfusionTHA patientsAntifibrinolytic agentsPatient groupSurgical approachIntraarticular injectionSubgroup analysisJoint arthroplastyArthroplastyPatientsAdministrationSubgroupsStudy model
2014
Enhanced Recovery After Surgery Protocols for Open Hepatectomy—Physiology, Immunomodulation, and Implementation
Page A, Ejaz A, Spolverato G, Zavadsky T, Grant M, Galante D, Wick E, Weiss M, Makary M, Wu C, Pawlik T. Enhanced Recovery After Surgery Protocols for Open Hepatectomy—Physiology, Immunomodulation, and Implementation. Journal Of Gastrointestinal Surgery 2014, 19: 387-399. PMID: 25472030, DOI: 10.1007/s11605-014-2712-0.Peer-Reviewed Original ResearchConceptsApplication of ERASBlood product transfusionImplementation of ERASUse of opioidsPerioperative inflammationERAS protocolPerioperative outcomesProduct transfusionColorectal surgeryERAS principlesInflammatory stressorsPerioperative protocolSurgery protocolBlood lossPerioperative fastingBiliary surgeryEnhanced recoverySurgical communitySurgeryNormal physiologyHepatectomyERASSubspecialty fieldsLaparotomyOpioidsVariation in transfusion rates within a single institution: Exploring the effect of differing practice patterns on the likelihood of blood product transfusion in patients undergoing cardiac surgery
Cote C, MacLeod J, Yip A, Ouzounian M, Brown C, Forgie R, Pelletier M, Hassan A. Variation in transfusion rates within a single institution: Exploring the effect of differing practice patterns on the likelihood of blood product transfusion in patients undergoing cardiac surgery. Journal Of Thoracic And Cardiovascular Surgery 2014, 149: 297-302. PMID: 25300883, DOI: 10.1016/j.jtcvs.2014.09.004.Peer-Reviewed Original ResearchConceptsRate of perioperative transfusionPerioperative transfusion ratesPerioperative transfusionTransfusion rateCardiac surgeryPractice patternsIntraoperative variablesPredictors of perioperative transfusionPredictors of blood transfusionOverall transfusion rateBlood product transfusionRisk-adjusted effectYear of procedureProduct transfusionBlood transfusionClinical predictorsIndependent predictorsClinical characteristicsClinical factorsTransfusionPatientsStudy populationSurgeryMultivariable regression modeling techniquesNonclinical factors
2012
Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial
Balaguer JM, Yu C, Byrne JG, Ball SK, Petracek MR, Brown NJ, Pretorius M. Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial. Clinical Pharmacology & Therapeutics 2012, 93: 326-334. PMID: 23361105, PMCID: PMC4031681, DOI: 10.1038/clpt.2012.249.Peer-Reviewed Original ResearchConceptsBradykinin B2 receptor antagonismB2 receptor antagonismCardiopulmonary bypassEndogenous bradykininTissue-type plasminogen activatorHoe 140Receptor antagonismBradykinin B2 receptor antagonistSubsequent transfusion requirementsBlood product transfusionProportion of patientsB2 receptor antagonistD-dimer concentrationD-dimer formationEACA treatmentTransfusion requirementsPostoperative bleedingProduct transfusionBlood lossCardiac surgeryInflammatory cytokinesReceptor antagonistClinical trialsFibrinolytic capacityInflammatory response109 The Impact of Differences in Practice Patterns on Rates of Blood Product Transfusion Following Cardiac Surgery
Hassan A, MacLeod J, Yip A, Ouzounian M, Hirsch G, Cloutier J, O'Reilly B, Brown C, Forgie R, Pelletier M. 109 The Impact of Differences in Practice Patterns on Rates of Blood Product Transfusion Following Cardiac Surgery. Canadian Journal Of Cardiology 2012, 28: s129-s130. DOI: 10.1016/j.cjca.2012.07.118.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply